300146 汤臣倍健
已收盘 01-07 15:00:00
资讯
新帖
简况
股市必读：汤臣倍健（300146）12月23日董秘有最新回复
证券之星 · 2025-12-24
股市必读：汤臣倍健（300146）12月23日董秘有最新回复
汤臣倍健：公司无应收账款质押情形
证券之星 · 2025-12-23
汤臣倍健：公司无应收账款质押情形
汤臣倍健：坚持差异化战略打造产品科技力
证券之星 · 2025-12-18
汤臣倍健：坚持差异化战略打造产品科技力
【机构调研记录】长盛基金调研汤臣倍健、博苑股份
证券之星 · 2025-12-10
【机构调研记录】长盛基金调研汤臣倍健、博苑股份
汤臣倍健：第四季度业绩受销售活动安排影响
证券之星 · 2025-12-09
汤臣倍健：第四季度业绩受销售活动安排影响
11月27日汤臣倍健发生1笔大宗交易 成交金额230.14万元
证券之星 · 2025-11-27
11月27日汤臣倍健发生1笔大宗交易 成交金额230.14万元
股市必读：汤臣倍健（300146）11月18日披露最新机构调研信息
证券之星 · 2025-11-20
股市必读：汤臣倍健（300146）11月18日披露最新机构调研信息
汤臣倍健：有知名机构正圆投资参与的多家机构于11月18日调研我司
证券之星 · 2025-11-19
汤臣倍健：有知名机构正圆投资参与的多家机构于11月18日调研我司
股市必读：汤臣倍健（300146）11月14日董秘有最新回复
证券之星 · 2025-11-17
股市必读：汤臣倍健（300146）11月14日董秘有最新回复
中原证券：运动营养市场为“基数小、增速快”的蓝海 关注汤臣倍健(300146.SZ)等基本面变化
智通财经 · 2025-11-14
中原证券：运动营养市场为“基数小、增速快”的蓝海 关注汤臣倍健(300146.SZ)等基本面变化
股市必读：汤臣倍健（300146）11月13日董秘有最新回复
证券之星 · 2025-11-14
股市必读：汤臣倍健（300146）11月13日董秘有最新回复
汤臣倍健：膳食营养补充剂行业发展将受益于国民健康意识提升
证券之星 · 2025-11-13
汤臣倍健：膳食营养补充剂行业发展将受益于国民健康意识提升
汤臣倍健副总陈宏为公司创始人之一 去年薪酬305.3万元 比总经理还高
运营商财经网 · 2025-11-09
汤臣倍健副总陈宏为公司创始人之一 去年薪酬305.3万元 比总经理还高
汤臣倍健：天风证券、中金公司等多家机构于10月31日调研我司
证券之星 · 2025-11-03
汤臣倍健：天风证券、中金公司等多家机构于10月31日调研我司
股市必读：汤臣倍健（300146）10月30日披露最新机构调研信息
证券之星 · 2025-10-31
股市必读：汤臣倍健（300146）10月30日披露最新机构调研信息
汤臣倍健(300146)9月30日股东户数7.11万户，较上期减少0.14%
证券之星 · 2025-10-29
汤臣倍健(300146)9月30日股东户数7.11万户，较上期减少0.14%
汤臣倍健最新公告：第三季度净利润1.71亿元同比扭亏
中金财经 · 2025-10-29
汤臣倍健最新公告：第三季度净利润1.71亿元同比扭亏
股市必读：汤臣倍健（300146）10月23日董秘有最新回复
证券之星 · 2025-10-24
股市必读：汤臣倍健（300146）10月23日董秘有最新回复
汤臣倍健：轻络素申报尚在审批中
证券之星 · 2025-10-23
汤臣倍健：轻络素申报尚在审批中
股市必读：汤臣倍健（300146）10月13日董秘有最新回复
证券之星 · 2025-10-14
股市必读：汤臣倍健（300146）10月13日董秘有最新回复
加载更多
公司概况
公司名称：
汤臣倍健股份有限公司
所属行业：
食品制造业
上市日期：
2010-12-15
主营业务：
汤臣倍健股份有限公司的主营业务是膳食营养补充剂的生产销售。公司的主要产品是片剂、粉剂、胶囊、其他。截至报告期末，公司获得134项原料及配方等发明专利。
发行价格：
110.00
{"stockData":{"symbol":"300146","market":"SZ","secType":"STK","nameCN":"汤臣倍健","latestPrice":12.15,"timestamp":1767769398000,"preClose":12.36,"halted":0,"volume":16316322,"delay":0,"changeRate":-0.017,"floatShares":1121000000,"shares":1692000000,"eps":0.4088,"marketStatus":"已收盘","change":-0.21,"latestTime":"01-07 15:00:00","open":12.36,"high":12.37,"low":12.1,"amount":200000000,"amplitude":0.0218,"askPrice":12.16,"askSize":111,"bidPrice":12.15,"bidSize":962,"shortable":0,"etf":0,"ttmEps":0.4088,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1767835800000},"marketStatusCode":5,"adr":0,"adjPreClose":12.36,"symbolType":"stock","openAndCloseTimeList":[[1767749400000,1767756600000],[1767762000000,1767769200000]],"highLimit":13.6,"lowLimit":11.12,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":1691677031,"isCdr":false,"pbRate":1.85,"roa":"--","peRate":29.721135,"roe":"8.12%","epsLYR":0.39,"committee":0.683102,"marketValue":20554000000,"turnoverRate":0.0146,"status":1,"floatMarketCap":13618000000},"requestUrl":"/m/hq/s/300146","defaultTab":"news","newsList":[{"id":"2593141732","title":"股市必读：汤臣倍健（300146）12月23日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2593141732","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593141732?lang=zh_cn&edition=full","pubTime":"2025-12-24 02:33","pubTimestamp":1766514790,"startTime":"0","endTime":"0","summary":"截至2025年12月23日收盘，汤臣倍健报收于12.02元，下跌1.15%，换手率1.16%，成交量12.98万手，成交额1.57亿元。董秘最新回复投资者： 尊敬的董秘，您好！2024年年报，短期借款激增至15.43亿元，年报显示是“已贴现未到期商业汇票”，请问这是质押的应收账款吗？上述主要系公司基于整体资金安排进行票据贴现业务所致，公司无应收账款质押情形。当日关注点来自交易信息汇总：12月23日主力资金净流出1099.32万元，散户资金净流入1564.95万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122400001023.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300146","BK0028","BK0114","BK0146","BK0042","BK0107","BK0226"],"gpt_icon":0},{"id":"2593462320","title":"汤臣倍健：公司无应收账款质押情形","url":"https://stock-news.laohu8.com/highlight/detail?id=2593462320","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593462320?lang=zh_cn&edition=full","pubTime":"2025-12-23 15:06","pubTimestamp":1766473579,"startTime":"0","endTime":"0","summary":"证券之星消息，汤臣倍健(300146)12月23日在投资者关系平台上答复投资者关心的问题。投资者提问：尊敬的董秘，您好！2024年年报，短期借款激增至15.43亿元，年报显示是“已贴现未到期商业汇票”，请问这是质押的应收账款吗？如果是，为什么“应收账款”科目仅有1.65亿？是遗漏了吗？激增这么多借款的原因是什么？谢谢！汤臣倍健回复：投资者您好！上述主要系公司基于整体资金安排进行票据贴现业务所致，公司无应收账款质押情形。感谢关注。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122300018874.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300146","BK0146","BK0226","BK0028","BK0107","BK0042","BK0114"],"gpt_icon":0},{"id":"2592920997","title":"汤臣倍健：坚持差异化战略打造产品科技力","url":"https://stock-news.laohu8.com/highlight/detail?id=2592920997","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592920997?lang=zh_cn&edition=full","pubTime":"2025-12-18 15:06","pubTimestamp":1766041587,"startTime":"0","endTime":"0","summary":"证券之星消息，汤臣倍健12月18日在投资者关系平台上答复投资者关心的问题。差异化是用户需求而其它企业没能满足的东西，而非仅仅是与众不同。没有差异化产品的商业模式基本不是好的商业模式。公司坚持执行差异化战略，在全球范围内科学甄选优质原料，深入开展自有知识产权原料、新功能和重功能创新产品开发，持续打造产品科技力和差异化竞争优势。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121800017388.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0226","300146","BK0146","BK0042","BK0107","BK0028","BK0114"],"gpt_icon":0},{"id":"2590037861","title":"【机构调研记录】长盛基金调研汤臣倍健、博苑股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2590037861","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590037861?lang=zh_cn&edition=full","pubTime":"2025-12-10 08:05","pubTimestamp":1765325146,"startTime":"0","endTime":"0","summary":"证券之星消息，根据市场公开信息及12月9日披露的机构调研信息，长盛基金近期对2家上市公司进行了调研，相关名单如下：1）汤臣倍健 调研纪要：公司聚焦主业，推动长期有质量发展。第四季度净利润受费用投放、奖金计提等影响。2）博苑股份 调研纪要：公司精细化学品主要包括碘化物、发光材料、六甲基二硅氮烷和贵金属催化剂，其中碘化物为营收核心。2025年12月11日将解除限售19,630,000股，目前未收到股东减持计划通知。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121000004481.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0107","BK0226","BK0229","BK0114","BK0042","BK0028","BK0146","300146","301617"],"gpt_icon":0},{"id":"2590121143","title":"汤臣倍健：第四季度业绩受销售活动安排影响","url":"https://stock-news.laohu8.com/highlight/detail?id=2590121143","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590121143?lang=zh_cn&edition=full","pubTime":"2025-12-09 18:12","pubTimestamp":1765275130,"startTime":"0","endTime":"0","summary":"证券之星消息，汤臣倍健12月09日在投资者关系平台上答复投资者关心的问题。另外，为什么过去几年，每年公司Q4都会出现业绩下滑？谢谢汤臣倍健回复：投资者您好！公司坚持规范信息披露，严格遵守法律法规的有关规定管理未公开信息，不存在内幕信息泄露或违反公平信披原则等违规情形。公司第四季度业绩受销售活动安排、市场费用投放节奏、奖金计提和费用结算等因素影响。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120900029030.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300146","BK0146","BK0226","BK0028","BK0107","BK0042","BK0114"],"gpt_icon":0},{"id":"2586246182","title":"11月27日汤臣倍健发生1笔大宗交易 成交金额230.14万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2586246182","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586246182?lang=zh_cn&edition=full","pubTime":"2025-11-27 17:41","pubTimestamp":1764236517,"startTime":"0","endTime":"0","summary":"证券之星消息，11月27日汤臣倍健发生大宗交易，交易数据如下：大宗交易成交价格12.44元，相对当日收盘价溢价1.8%，成交18.5万股，成交金额230.14万元，买方营业部为光大证券股份有限公司宁波柳汀街证券营业部，卖方营业部为光大证券股份有限公司宁波柳汀街证券营业部。近三个月该股共发生2笔大宗交易，合计成交3709.0手，折价成交1笔，溢价成交1笔。截至2025年11月27日收盘，汤臣倍健报收于12.22元，下跌0.65%，换手率1.03%，成交量11.52万手，成交额1.42亿元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112700025876.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","300146","BK0114","BK0226","BK0107","BK0146","BK0042"],"gpt_icon":0},{"id":"2584921736","title":"股市必读：汤臣倍健（300146）11月18日披露最新机构调研信息","url":"https://stock-news.laohu8.com/highlight/detail?id=2584921736","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584921736?lang=zh_cn&edition=full","pubTime":"2025-11-20 01:04","pubTimestamp":1763571858,"startTime":"0","endTime":"0","summary":"截至2025年11月18日收盘，汤臣倍健报收于12.7元，上涨0.79%，换手率2.25%，成交量25.27万手，成交额3.2亿元。当日关注点来自交易信息汇总：11月18日主力资金净流出1165.23万元，散户资金净流入394.8万元。来自机构调研要点：主品牌“汤臣倍健”定位全系列覆盖全人群，“健力多”与“lifespace”营收占比均已超10%。行业增量来自渗透率提升与新增人群扩容，VDS行业仍具增长空间。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112000000453.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0146","BK0107","BK0114","BK0042","BK0028","300146","BK0226"],"gpt_icon":0},{"id":"2584995365","title":"汤臣倍健：有知名机构正圆投资参与的多家机构于11月18日调研我司","url":"https://stock-news.laohu8.com/highlight/detail?id=2584995365","media":"证券之星","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584995365?lang=zh_cn&edition=full","pubTime":"2025-11-19 10:02","pubTimestamp":1763517749,"startTime":"0","endTime":"0","summary":"证券之星消息，2025年11月18日汤臣倍健发布公告称国盛证券陈熠、东吴证券邓洁、财通证券张立、易方达基金易俊何、中科沃土基金彭上、建信养老官忠涛、长江自营高辰星、广发自营高峰、正圆投资冯荃晴于2025年11月18日调研我司。汤臣倍健主营业务：膳食营养补充剂的研发、生产和销售。该股最近90天内共有7家机构给出评级，买入评级2家，增持评级4家，中性评级1家；过去90天内机构目标均价为14.25。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111900008869.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0107","300146","BK0028","BK0114","BK0042","BK0146","BK0226"],"gpt_icon":0},{"id":"2584660270","title":"股市必读：汤臣倍健（300146）11月14日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2584660270","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584660270?lang=zh_cn&edition=full","pubTime":"2025-11-17 01:17","pubTimestamp":1763313430,"startTime":"0","endTime":"0","summary":"截至2025年11月14日收盘，汤臣倍健报收于12.72元，下跌2.53%，换手率2.37%，成交量26.54万手，成交额3.42亿元。董秘最新回复投资者： 给公司提个建议：买了你们家儿童增高产品，但小朋友经常忘记按时吃，大人也不可能老提醒，所以，建议针对小朋友的营养健康产品，最好能配搭提供一个“提醒功能”的小电子玩具。每天提醒小朋友自觉服用。交易信息汇总资金流向11月14日主力资金净流出3219.86万元；游资资金净流入1697.62万元；散户资金净流入1522.25万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111700000469.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0042","BK0226","300146","BK0114","BK0146","BK0107","BK0028"],"gpt_icon":0},{"id":"2583081540","title":"中原证券：运动营养市场为“基数小、增速快”的蓝海 关注汤臣倍健(300146.SZ)等基本面变化","url":"https://stock-news.laohu8.com/highlight/detail?id=2583081540","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2583081540?lang=zh_cn&edition=full","pubTime":"2025-11-14 11:20","pubTimestamp":1763090429,"startTime":"0","endTime":"0","summary":"整体看，运动营养市场呈现“基数小、增速快”的蓝海特征。A股上市公司中涉足运动营养的上市公司主要包括康比特、汤臣倍健和西王食品，建议关注这些上市公司的基本面变化。中国运动营养市场的增长远快于全球水平：2024年中国运动营养食品市场规模为97.1亿元，预计2030年增至209.3亿元，年均增长11.56%。与国际市场不同，在中国运动营养的市场集中度较高根据核算，截至2024年中国运动营养市场CR3达到70%，头部企业包括西王食品、康比特和汤臣倍健等。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1369190.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0276","601375","BK0028","BK0107","300146","BK0114","BK0146","BK0226","BK0042","BK0201"],"gpt_icon":0},{"id":"2583165925","title":"股市必读：汤臣倍健（300146）11月13日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2583165925","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2583165925?lang=zh_cn&edition=full","pubTime":"2025-11-14 03:32","pubTimestamp":1763062335,"startTime":"0","endTime":"0","summary":"截至2025年11月13日收盘，汤臣倍健报收于13.05元，上涨1.08%，换手率2.26%，成交量25.31万手，成交额3.27亿元。膳食营养补充剂行业发展将受益于国民健康意识提升、人口老龄化趋势加深及新生代消费群体扩容等。当日关注点来自交易信息汇总：11月13日主力资金净流入565.84万元，显示主力对个股呈积极介入态势。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111400003148.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0114","BK0028","300146","BK0042","BK0107","BK0146","BK0226"],"gpt_icon":0},{"id":"2583553941","title":"汤臣倍健：膳食营养补充剂行业发展将受益于国民健康意识提升","url":"https://stock-news.laohu8.com/highlight/detail?id=2583553941","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2583553941?lang=zh_cn&edition=full","pubTime":"2025-11-13 11:34","pubTimestamp":1763004845,"startTime":"0","endTime":"0","summary":"证券之星消息，汤臣倍健(300146)11月13日在投资者关系平台上答复投资者关心的问题。投资者提问：随着智能体、机器人的发展，机器代替人是大趋势，我国劳动就业率会长期不足，老百姓收入减少，相应的可选保健品购买也会减少。请问，公司如何应对这一宏观趋势？汤臣倍健回复：投资者您好！膳食营养补充剂行业发展将受益于国民健康意识提升、人口老龄化趋势加深及新生代消费群体扩容等。公司将持续关注经济环境与市场需求变化，适时调整经营策略。感谢关注。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111300016788.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0146","BK0028","BK0107","300146","BK0226","BK0042","BK0114"],"gpt_icon":0},{"id":"2582899900","title":"汤臣倍健副总陈宏为公司创始人之一 去年薪酬305.3万元 比总经理还高","url":"https://stock-news.laohu8.com/highlight/detail?id=2582899900","media":"运营商财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582899900?lang=zh_cn&edition=full","pubTime":"2025-11-09 16:59","pubTimestamp":1762678740,"startTime":"0","endTime":"0","summary":"可以看出，陈宏为汤臣倍健初始创业人员之一，是元老级员工，已在公司副总经理职位上工作近20年。陈宏2024年薪酬为305.3万元，相较于2023年的500.0万元，下降了194.7万元，但仍高于总经理林志成，后者去年薪酬为230.7万元。汤臣倍健三季度财报显示，公司前三季度营业收入为49.15亿元，同比下降14.27%，归母净利润为9.07亿元，同比增长4.45%，呈现增利不增收的情形。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2025-11-09/doc-infwuxct2463004.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0226","BK0042","BK0114","300146","BK0028","BK0107","BK0146"],"gpt_icon":0},{"id":"2580259665","title":"汤臣倍健：天风证券、中金公司等多家机构于10月31日调研我司","url":"https://stock-news.laohu8.com/highlight/detail?id=2580259665","media":"证券之星","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2580259665?lang=zh_cn&edition=full","pubTime":"2025-11-03 10:31","pubTimestamp":1762137074,"startTime":"0","endTime":"0","summary":"证券之星消息，2025年10月31日汤臣倍健发布公告称天风证券陈潇 马咏怡 吴艾锜、中金公司王文丹、交银施罗德基金傅爱兵、博时基金钟天皓、长城基金覃晓露 申忆扬于2025年10月31日调研我司。汤臣倍健主营业务：膳食营养补充剂的研发、生产和销售。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110300007445.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["SG9999002828.SGD","601162","BK0042","BK0028","BK0107","LU1580142542.USD","BK0114","300146","LU1781817850.SGD","601995","LU0359202008.SGD","BK0226","BK1564","BK0146","LU1023057109.AUD","BK1147","BK1501","BK0276","03908","BK1516","LU0359201885.HKD","LU0359201612.USD"],"gpt_icon":0},{"id":"2579789481","title":"股市必读：汤臣倍健（300146）10月30日披露最新机构调研信息","url":"https://stock-news.laohu8.com/highlight/detail?id=2579789481","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579789481?lang=zh_cn&edition=full","pubTime":"2025-10-31 01:42","pubTimestamp":1761846133,"startTime":"0","endTime":"0","summary":"截至2025年10月30日收盘，汤臣倍健报收于12.71元，上涨2.25%，换手率6.43%，成交量72.07万手，成交额9.33亿元。当日关注点来自交易信息汇总：10月30日主力资金净流出6399.68万元，散户资金净流入9216.02万元。来自机构调研要点：公司计划在2026年以“再创业”心态全线出击，聚焦产品创新与全球市场拓展。公司持续关注商誉是否存在减值迹象，并在每年度末聘请专业评估机构进行减值测试，具体请以公司定期报告为准。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025103100002477.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0226","300146","BK0146","BK0042","BK0107","BK0028","BK0114"],"gpt_icon":0},{"id":"2579786789","title":"汤臣倍健(300146)9月30日股东户数7.11万户，较上期减少0.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2579786789","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579786789?lang=zh_cn&edition=full","pubTime":"2025-10-29 17:33","pubTimestamp":1761730409,"startTime":"0","endTime":"0","summary":"证券之星消息，近日汤臣倍健披露，截至2025年9月30日公司股东户数为7.11万户，较6月30日减少100.0户，减幅为0.14%。在食品加工行业个股中，汤臣倍健股东户数高于行业平均水平，截至9月30日，食品加工行业平均股东户数为3.52万户。从股价来看，2025年6月30日至2025年9月30日，汤臣倍健区间涨幅为2.58%，在此期间股东户数减少100.0户，减幅为0.14%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102900036373.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300146","BK0107","BK0146","BK0226","BK0042","BK0114","BK0028"],"gpt_icon":0},{"id":"2579592094","title":"汤臣倍健最新公告：第三季度净利润1.71亿元同比扭亏","url":"https://stock-news.laohu8.com/highlight/detail?id=2579592094","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579592094?lang=zh_cn&edition=full","pubTime":"2025-10-29 17:11","pubTimestamp":1761729079,"startTime":"0","endTime":"0","summary":"汤臣倍健(300146.SZ)发布2025年三季报，公司第三季度营业收入13.83亿元，同比增长23.45%；净利润1.71亿元，上年同期亏损2241.65万元。2025年前三季度营业收入49.15亿元，同比下降14.27%；净利润9.07亿元，同比增长4.45%；基本每股收益0.53元。第三季度，公司持续调整优化各渠道业务策略，单三季度收入和净利润同比均实现增长。为证券之星据公开信息整理，由AI算法生成(网信算备310104345710301240019号)，不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushiyaowen/20251029/31747384.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["300146"],"gpt_icon":0},{"id":"2577158212","title":"股市必读：汤臣倍健（300146）10月23日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2577158212","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577158212?lang=zh_cn&edition=full","pubTime":"2025-10-24 01:14","pubTimestamp":1761239649,"startTime":"0","endTime":"0","summary":"截至2025年10月23日收盘，汤臣倍健报收于12.06元，下跌0.41%，换手率1.37%，成交量15.32万手，成交额1.84亿元。董秘最新回复投资者： 请问轻络素审核是否已通过？公司已递交相关申报，目前尚在审批中。当日关注点来自交易信息汇总：10月23日主力资金净流出3045.98万元，显示主力短期减持动向。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102400001219.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0042","BK0226","300146","BK0114","BK0146","BK0107","BK0028"],"gpt_icon":0},{"id":"2577370463","title":"汤臣倍健：轻络素申报尚在审批中","url":"https://stock-news.laohu8.com/highlight/detail?id=2577370463","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577370463?lang=zh_cn&edition=full","pubTime":"2025-10-23 18:27","pubTimestamp":1761215228,"startTime":"0","endTime":"0","summary":"证券之星消息，汤臣倍健(300146)10月23日在投资者关系平台上答复投资者关心的问题。投资者提问：请问轻络素审核是否已通过？汤臣倍健回复：投资者您好！公司已递交相关申报，目前尚在审批中。感谢关注。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102300030652.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300146","BK0226","BK0042","BK0114","BK0028","BK0107","BK0146"],"gpt_icon":0},{"id":"2575890722","title":"股市必读：汤臣倍健（300146）10月13日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2575890722","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2575890722?lang=zh_cn&edition=full","pubTime":"2025-10-14 01:37","pubTimestamp":1760377029,"startTime":"0","endTime":"0","summary":"截至2025年10月13日收盘，汤臣倍健报收于11.64元，下跌1.1%，换手率1.6%，成交量17.96万手，成交额2.08亿元。董秘最新回复投资者： 假设公司向山区儿童捐献维生素相关等相关产品，按照目前相关法律法规规定是否合规？","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025101400027123.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0107","BK0146","BK0114","BK0226","BK0042","300146"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1767770482281,"stockEarnings":[{"period":"1week","weight":0.0223},{"period":"1month","weight":0.0369},{"period":"3month","weight":0.072},{"period":"6month","weight":0.0757},{"period":"1year","weight":0.0998},{"period":"ytd","weight":0.0291}],"compareEarnings":[{"period":"1week","weight":0.0299},{"period":"1month","weight":0.0463},{"period":"3month","weight":0.0517},{"period":"6month","weight":0.1635},{"period":"1year","weight":0.2734},{"period":"ytd","weight":0.0289}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"汤臣倍健股份有限公司","boardCode":"AI0014","boardName":"食品制造业","stockholders":"71105人(较上一季度减少0.14%)","perCapita":"15762股","listingDate":"2010-12-15","address":"广东省珠海市金湾区三灶科技工业园星汉路19号","registeredCapital":"169167万元","survey":" 汤臣倍健股份有限公司的主营业务是膳食营养补充剂的生产销售。公司的主要产品是片剂、粉剂、胶囊、其他。截至报告期末，公司获得134项原料及配方等发明专利。","listedPrice":110},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.13","shortVersion":"4.35.13","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"汤臣倍健(300146)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供汤臣倍健(300146)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"汤臣倍健,300146,汤臣倍健股票,汤臣倍健股票老虎,汤臣倍健股票老虎国际,汤臣倍健行情,汤臣倍健股票行情,汤臣倍健股价,汤臣倍健股市,汤臣倍健股票价格,汤臣倍健股票交易,汤臣倍健股票购买,汤臣倍健股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"汤臣倍健(300146)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供汤臣倍健(300146)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}